Cannara signs exclusive brand partnership with Exotic Genetix in Canada

Agreement grants Cannara an exclusive license to use, sell and distribute Exotic Genetix branded products through Canada, in addition to providing access to breeders’ first-hand knowledge and insight into Exotic Genetix’s cannabis strains

MONTREAL, August 3, 2022 /PRNewswire/ – Cannara Biotech Inc. (“Cannara” or the “Company”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium cannabis and derivative products with the one of the largest indoor cannabis grow facilities Canada and the greatest of Quebec, today announced an exclusive brand partnership with Exotic Genetix Ltd. (“Exotic Genetix”), 50-time award-winning American cannabis breeder, grower and hash maker. This deal will bring one of the most influential cannabis breeders and its brands from the United States to Canada.

“We are thrilled to announce this partnership with one of the top seed breeders in this industry,” said Nicholas Sosiak, CFO of Cannara. “Exotic Genetix is ​​a multi-award winning breeder and is responsible for the genetics behind some of the highest quality cannabis available in United States. Exotic Genetix cannabis strains are currently core products in Cannara’s portfolio, representing 5 of our 8 current flagship genetics, and we can attest to the high demand and satisfaction stemming from these genetics among our current customers. We couldn’t be happier to partner with Exotic Mike, the founder of Exotic Genetix, and the rest of the Exotic Genetix team to continue to achieve our goal of producing the highest quality, affordable cannabis for our clients. We are proud to have been chosen as the exclusive partner to extend the reach of Exotic Genetix to Canada and have no doubt that both companies and our customers will all benefit from this effort,” concluded Mr. Sosiak.

A testament to the quality of its cannabis, the Exotic Genetix strains comprise five of the eight genetics cultivated by Cannara, including Gelato Mint, Power Sherb, Galactic Runtz, CBD Runtz and Slapz.

Under the terms of the agreement, Cannara will be granted an exclusive license to use, market, sell and distribute Exotic Genetix branded products throughout the Canada. In addition, Exotic Genetix will provide Cannara with ongoing consulting services with respect to the provision of knowledge and information on cannabis genetics, plant cultivation methodologies, and marketing services.

“I’ve been waiting a long time to bring Exotic Genetix to Canada and who better to organize the brand than Cannara alongside its flagship brands Tribal, Nugz and Orchid CBD. Their unwavering commitment and ability to grow top quality cannabis on a large scale in state-of-the-art facilities provides the perfect opportunity to begin our journey in Canada. We look forward to bringing Canadians the highest quality cannabis at prices that can fit everyone’s budget,” said Exotic Mike.

About Cannara Biotech Inc.

Cannara Biotech Inc. (TSXV:LOVE) (OTCQB:LOVFF) (FRA:8CB) is a vertically integrated producer of premium cannabis and cannabis-derived products for the Quebec and Canadian markets. Cannara has two Quebec-based mega-facilities spanning over 1,650,000 square feet, providing the Company with an annualized production potential of 125,000 kg. Taking advantage of Quebec’s low electricity costs, Cannara’s facilities produce premium quality cannabis products at an affordable price. For more information, please visit

About Exotic Genetix

Founded in 2008, Exotic Genetix is ​​a US-based company that specializes in breeding original cannabis genetics that have won Cannabis Cups every year since 2012. Exotic Mike is a seed breeder, grower and hash maker. awarded 50 times in the United States. the legendary creator and artist behind Exotic Genetix. For more information, please visit

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Cannara Biotech Inc.

Comments are closed.